GCG and metabolic dysfunction-associated steatotic liver disease: Glucagon resistance has previously been reported in patients with obesity and NAFLD [3,6] but here we demonstrate glucagon resistance in mice fed a cholesterol-rich diet for just seven days, a period sufficiently short to result in no alteration in body weight nor hepatic fat content.